Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Australia's CSL reaffirms commitment to making AstraZeneca COVID vaccine

10/13/2021 | 07:15pm EDT
FILE PHOTO: Vials labelled

Oct 14 (Reuters) - Australian biotech CSL said on Thursday it was committed to its agreement for the production of about 50 million doses of AstraZeneca's COVID-19 vaccine into 2022.

The announcement came after a media report said the British drugmaker's vaccine, Vaxzevria, will no longer be manufactured in Australia due to demand for vaccines of Pfizer and Moderna.

Pfizer and Moderna have established a market dominance by using mRNA-based COVID-19 vaccine technology to fight the pandemic.

CSL, in a brief statement https://www.csl.com/news/2021/20211014-csl-reaffirms-commitment-to-manufacture-astrazeneca-covid-vaccine-into-2022, added that more than 20 million of the doses have already been produced, and it is expected that the remaining production will be completed early next year.

Cafes, gyms and restaurants in Sydney welcomed back fully vaccinated customers earlier this week after nearly four months of a lockdown, as Australia aims to begin living with the coronavirus and gradually reopen with high rates of inoculation. (Reporting by Indranil Sarkar in Bengaluru; Editing by Maju Samuel)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 0.30% 8795 Delayed Quote.19.72%
CSL LIMITED 0.50% 297.67 End-of-day quote.5.12%
MODERNA, INC. -0.18% 333.01 Delayed Quote.218.76%
All news about ASTRAZENECA PLC
04:48aASTRAZENECA : JP Morgan reaffirms its Buy rating
MD
10/20ASTRAZENECA : Credit Suisse remains its Buy rating
MD
10/20ASTRAZENECA : Announces Winners and Recognizes Oncology Change Makers in Third Annual Canc..
BU
10/20ASTRAZENECA : Air Malta Transports Maltese Solidarity to Rwanda; 135,690 AstraZeneca vacci..
AQ
10/20KAROLINSKA INSTITUTET : Two COVID-19 Vaccine Doses Increase Airway Antibodies After Infect..
MT
10/20MODERNA : Germany may miss COVID-19 vaccine donation goal, blames manufacturers
RE
10/20ASTRAZENECA : Conference Chair Di Morris, AstraZeneca Invites You to Join SMi's 10th Annua..
AQ
10/20LONDON STOCK EXCHANGE : Nearly half of FTSE 100 companies have no net-zero target, Arabesq..
RE
10/20ASTRAZENECA : India delays COVID-19 vaccine supplies to WHO-backed COVAX, sources say
RE
10/19ASTRAZENECA : WHO-led programme aims to buy antiviral COVID-19 pills for $10 -document
RE
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 441 M - -
Net income 2021 4 862 M - -
Net Debt 2021 24 847 M - -
P/E ratio 2021 35,1x
Yield 2021 2,33%
Capitalization 188 B 188 B -
EV / Sales 2021 6,00x
EV / Sales 2022 4,85x
Nbr of Employees 76 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 121,17 $
Average target price 137,81 $
Spread / Average Target 13,7%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC19.72%187 751
JOHNSON & JOHNSON4.07%431 148
ROCHE HOLDING AG13.98%333 101
PFIZER, INC.14.34%239 966
NOVO NORDISK A/S56.26%238 738
ELI LILLY AND COMPANY44.35%220 952